amyloidosis; systemic
Showing 1 - 5 of 5
Amyloidosis; Systemic Trial in Woolloongabba, Box Hill (AT02)
Not yet recruiting
- Amyloidosis; Systemic
-
Woolloongabba, Queensland, Australia
- +1 more
Jul 11, 2023
Amyloidosis; Systemic Trial in Boston (Propylene Glycol-Free Melphalan Hydrochloride)
Terminated
- Amyloidosis; Systemic
- Propylene Glycol-Free Melphalan Hydrochloride
-
Boston, MassachusettsBoston Medical Center
Jul 1, 2022
Amyloidosis; Systemic Trial in Beijing (Daratumumab, Bortezomib, Dexamethasone)
Active, not recruiting
- Amyloidosis; Systemic
- Daratumumab
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
May 9, 2022
Amyloidosis; Systemic Trial in Knoxville (124I-AT03)
Recruiting
- Amyloidosis; Systemic
-
Knoxville, TennesseeUniversity of Tennessee Medical Center
Mar 14, 2022
Amyloidosis; Systemic Trial in Beijing (Doxycycline, Bortezomib, Cyclophosphamide)
Completed
- Amyloidosis; Systemic
- Doxycycline
- +3 more
-
Beijing, ChinaPeking Union Medical College Hospital
Feb 19, 2021